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Cytochrome c releaseMitochondria mediate both cell survival and death. The intrinsic apoptotic pathway is initiated by the perme-
abilization of the mitochondrial outer membrane to pro-apoptotic inter-membrane space (IMS) proteins.
Many pathways cause the egress of IMS proteins. Of particular interest is the ability of ceramide to self-
assemble into dynamic water-ﬁlled channels. The formation of ceramide channels is regulated extensively by
Bcl-2 family proteins and dihydroceramide. Here, we show that the chain length of biologically active ceramides
serves as an important regulatory factor. Ceramides are synthesized by a family of six mammalian ceramide
synthases (CerS) each of which produces a subset of ceramides that differ in their fatty acyl chain length. Various
ceramides permeabilize mitochondria differentially. Interestingly, the presence of very long chain ceramides re-
duces the potency of C16-mediated mitochondrial permeabilization indicating that the intercalation of the lipids
in the dynamic channel has a destabilizing effect, reminiscent of dihydroceramide inhibition of ceramide channel
formation (Stiban et al., 2006).Moreover,mitochondria isolated from cells overexpressing the ceramide synthase
responsible for the production of C16-ceramide (CerS5) are permeabilized faster upon the exogenous addition of
C16-ceramide whereas they are resistant to permeabilization with added C24-ceramide. On the other handmito-
chondria isolated from CerS2-overexpressing cells show the opposite pattern, indicating that the product of
CerS2 inhibits C16-channel formation ex vivo and vice versa. This interplay between different ceramidemetabolic
enzymes and their products adds a new dimension to the complexity of mitochondrial-mediated apoptosis, and
emphasizes its role as a key regulatory step that commits cells to life or death.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Ceramides are a family of lipid molecules whose functions exceed
merely being part of the structure of the membranes as was initially
presumed [2]. Ceramides are sphingolipids, composed of a sphingo-
sine backbone N-acylated with different fatty acyl-CoA. This N-
acylation reaction is performed by one of 6 mammalian ceramide
synthases (CerSs). While CerS can use sphingosine as a substrate, in
the cell, CerS utilizes sphinganine (dihydrosphingosine) to producesphingosine; C22-ceramide, N-
ceroyl-D-erythro-sphingosine;
bromide; CerS, ceramide syn-
e tween 20.
iochemistry, Birzeit University,
298 2162, 97 2 54 392 1144;
unp@gmail.com (M. Perera).
altimore, MD 21202.dihydroceramide since de novo ceramide synthesis pathway produces
sphinganine abundantly [3,4].
Interestingly, different CerSs produce different species of ceramides,
varying by the length of their hydrophobic tail. CerS2, for instance, pref-
erentially acylates sphinganine with very long chain fatty acyl-CoA
whereas CerS5 uses C16-fatty acyl-CoA as its substrate [4,5]. Ceramides
were shown by biochemical and biophysical methods to possess a
unique ability to perforate lipid bilayers, especially the mitochondrial
outer membrane, by forming water-ﬁlled channels [1,6–10]. This evi-
dence was later validated by transmission electron microscopy visuali-
zation of these channels in liposomes [11]. The current model of the
ceramide channel consists of layers of ceramide molecules stacked in
an anti-parallel fashion on top of one another to form ceramide col-
umns. The amide bond stacks in a manner similar to peptide bonds in
an alpha-helix stabilizing the channel. An ice-lattice-like structure of
hydrogen bonding between the hydroxyls further stabilizes the chan-
nel, holding adjacent ceramide columns together to form the lumen of
the channel [12] (reviewed in [6,13,14]). The ability of ceramides to per-
forate mitochondrial outer membranes was shown for ceramides with
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15]).
Ceramide has been implicated to play a key role in apoptosis, a form
of programmed cell death. During the initiation phase of apoptosis, mi-
tochondrial ceramide levels increase [16] and the mitochondrial outer
membrane starts to lose its integrity. When the mitochondrial outer
membrane becomes permeabilized, leading to the egress of cytochrome
c and other pro-apoptotic proteins from the IMS into the cytosol, the cell
is irreversibly committed to death [17]. Ceramide can form channels in
themitochondrial outermembranewhich are large enough to allow the
egress of all proteins that are known to be released during apoptosis [9].
Ceramide channels are also regulated by the Bcl-2 family of proteins,
which regulate apoptosis [18–20].
In order to study the initiation of apoptosis, the regulation of ceramide
channel formation is probed in this work. We hypothesize that there are
at least 6 mammalian CerS isozymes because the products of each have
different roles in the cell. We propose that the products of each CerS iso-
zyme can serve as inducers or blockers of ceramide channel formation de-
pending on their relative amounts. Overexpression of different CerSs
resulted in a differential outcome of radiation-induced apoptosis in
HeLa cells. CerS5 overexpression led to more cells undergoing apoptosis
whereas CerS2 overexpression protected cells from death [21]. In breast
and colon cancer cells, overexpression of CerS4 and CerS6 inhibited cellu-
lar proliferation whereas overexpression of CerS2 promoted proliferation
[22]. In a previous work, dihydroceramide hindered ceramide channel
formation by virtue of intercalating in the structured ceramide pore and
destabilizing it [1]. Here, we investigated the possibility that other cer-
amide structures, namely very long chain ceramides could have similar
effects on C16-ceramide channels, possibly by intercalating into the chan-
nel and altering channel stability. Indeed we ﬁnd that a mixture of
ceramides has the ability to interfere with the ability of each species to
permeabilize membranes. In addition, we ﬁnd that C16-ceramide has
the ability to form both large and small channels whereas C22-ceramide
was unable to form larger structures under our experimental setup.
2. Materials and methods
2.1. Materials
Sprague Dawley white laboratory rats were bred in the animal unit
facility at Birzeit University and were fed standard rodent diet. The ani-
mals were sacriﬁced by cervical dislocation and decapitation in accor-
dance to animal treatment regulations at the institution.
Reagents used in this research were procured from Sigma-Aldrich.
Lipid species were obtained from Avanti Polar Lipids (Alabaster, AL).
Human Embryonic Kidney cells (HEK 293T), and pCMV plasmids
carrying CerS2 and CerS5 genes as well as the control plasmid were
kindly gifted by Prof. Anthony H. Futerman, at the Weizmann Institute
of Science, Rehovot, Israel.
2.2. Isolation of rat liver mitochondria
Mitochondria were isolated from overnight-starved male rats (100–
150 g) according to published protocols [1,10,23]. Isolated mitochondria
were suspended in H-buffer (280 mMmannitol, 2 mM HEPES, 0.1 mM
EGTA, pH7.4) and kept on ice for the duration of experiment. The concen-
tration of mitochondrial protein was determined spectroscopically [1].
2.3. Cytochrome c permeability assay
The permeability of the outer membrane of isolated mitochondria
was measured indirectly as the rate of oxidation of exogenously-
added reduced cytochrome c [1,10]. In short, 11 mg of cytochrome c
was fully reduced with 4 mg of ascorbic acid in buffer Q (180 mM
NaCl, 20 mMHEPES, 10 mM EGTA, pH 7.5) for 5 min at room tempera-
ture. Excess ascorbic acid was removed by gel ﬁltration of the mixtureover Sephadex G-10 beads equilibratedwith buffer Q. The bright red el-
uent (reduced cytochrome c) was kept on ice for the duration of the
experiments.
When the outer membrane of isolated mitochondria is intact, respi-
ratory chain complex IV (cytochrome c oxidase), which is an integral
protein of the mitochondrial inner membrane, has no access to any
added cytochrome c, and hence the rate of oxidation of exogenous cyto-
chrome c should beminimal. If mitochondria are hypotonically shocked
in water, the outer membrane disintegrates and the rate of oxidation of
cytochrome c by the complex would be maximal (designated 100%).
The permeability of mitochondria under any given circumstances can
hence be measured as the rate of oxidation of cytochrome c compared
to the maximal rate of oxidation.
For intact mitochondria, concentrated mitochondrial suspension
was diluted to 0.2 mg/mL in H-buffer supplemented with 5 μM
antimycin A and 5 mM DNP (HAD-buffer). For hypotonically-lysed mi-
tochondria, mitochondria were diluted to 0.4 mg/mL in double distilled
water for 10 min on ice then the osmolarity was restored by the addi-
tion of an equal volume of 2× HAD-buffer (making the ﬁnal concentra-
tion of hypotonically-shocked mitochondria 0.2 mg/mL).
In all experiments, 25 μg of mitochondria (50 μL of 0.2 mg/mL) was
dispersed in 650 μL HAD and after 5 min incubation, the indicated
amount of C16-, C22-, C24-ceramide, or a mixture of ceramides was
added in a volume of 30 μL while vortexing. All lipids were added
from 2 mg/mL stocks in isopropanol. The volume of added isopropanol
never exceeded 8% of the total assay volume. Controls with similar vol-
umes of isopropanol were assayed in parallel. The mitochondrial sus-
pension was then incubated for 15 min at room temperature before
the assaywas performed. Reduced cytochrome c (~25 μM, ﬁnal concen-
tration)was added and the rate of oxidation wasmeasured immediate-
ly at 550nm. Volumeof solvent is kept constant in all samples andwhen
a premixed combination of ceramides was added.
2.4. Adenylate kinase assay
The release of adenylate kinase was performed as published [23]. In
short, 200 mg of isolated mitochondria was suspended in 3 mL of H-
buffer supplemented with 5 mg leupeptin, 5 mg aprotinin, and 5 mg
pepstatin (each from 5 mg/mL solutions, to make the ﬁnal volume of
suspended mitochondria 5 mL). Mitochondria were then treated with
40 μg (74 nmol) of C16-ceramide, 46 μg (74 nmol) of C22-ceramide, or
a pre-mixed mixture of 74 nmol C16- and 74 nmol of C22-ceramides.
At time points 0, 5, and 15 min (or 0, 10, 20 and 40 min) 1 mL was re-
moved and centrifuged at 14,000 rpm for 2min. The recovered superna-
tant (~900 μL)was removed and kept on ice. In each experiment, 300 μL
of the supernatant was mixed with 700 μL of the reaction mixture
(50 mM Tris, pH 7.5, 5 mM MgSO4, 10 mM glucose, 1 mM ADP, and
0.2 mM NADP+). After equilibrating for 1 min, 9 μL of the enzymemix-
ture (25 units of hexokinase and 25 units of glucose 6-phosphate dehy-
drogenase) was added, and the production of NADPH at 340 nm was
monitored.
2.5. Liposome permeabilization assays
Liposome permeabilization assays were performed as previously
published [23] following a ﬂuorescence dequenching protocol.
Unilamellar liposomes consisting of 93% asolectin and 7% cholesterol
were prepared in buffer LP containing 1.5 mM carboxyﬂuorescein,
6 mM DPX, 40 mM NaCl, 10 mM HEPES, and 1 mM EDTA, pH 7. After
5 cycles of freeze-thawing followed by the extrusion through a polycar-
bonate membrane, excess unloaded ﬂuorophore was removed by gel
ﬁltration on a Sephacryl S200 gel ﬁltration column. In a 96-well plate
10 μL of liposome suspension was diluted in 100 μL of 50 mM NaCl,
10 mM HEPES, and 1 mM EDTA, pH 7. The liposomes were assessed
for their ﬂuorescence in a TECAN spectroﬂuorometer. The excitation ﬁl-
ter was 492 nm and the emission ﬁlter was 520 nm for CF. Fluorescence
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C16- or C22-ceramide, or a mixture of both at an amount of 40 nmol
each) and the ﬂuorescence was measured kinetically. The total CF con-
tent in liposomes was assessed after the addition of 0.4% Triton X-100.
The results were normalized using the values of the Triton perme-
abilization as 100%.
2.6. SOX assay
The release of sulﬁte oxidase, a mitochondrial intermembrane space
protein of 120 kDa, was assayed according to Ganesan and colleagues
[24].
2.7. Cytochrome c release and Western blotting
Human embryonic kidney (HEK 293T) cells were grown in DMEM
supplemented with 2 mM L-glutamine, 100 IU/mL penicillin, 100 μg/mL
streptomycin and 10% fetal bovine serum in a 5% CO2 incubator at 37 °C
until ~80% conﬂuent. The cells were then transfected with the genes
encoding CerS2 or CerS5 in a pCMV plasmid (20 μg of vector DNA con-
taining CerS genes per 10 cm culture plate) using the calcium phos-
phate method [25,26]. Control cells were mock transfected with a
pCMV only vector lacking any gene of interest. Twenty-four hours
post-transfection, cells were collected by mild trypsinization. Cells
were homogenized in H-buffer andmitochondria were isolated. Exoge-
nous C16-ceramide or C24-ceramide (74 nmol) was added and the mix-
ture was incubated for 20 min at room temperature. The suspensions
were spun down at 14,000 rpm for 2 min. The ensuing pellets and su-
pernatants were collected, and protein content was measured by
Bradford assay. The pellets and supernatants were then mixed with
5× sample buffer and ﬂash frozen in N2(l) for SDS-PAGE analysis. Gel
electrophoresis was performed on 17% polyacrylamide gels. In each
well, 100 μg of each protein was loaded. Electrophoresis was carried
out at constant current (25 mA per gel) for an hour. The gels were sub-
sequently transferred onto nitrocellulosemembranes and blocked with
TBST and 5% fat-free milk. Anti-cytochrome c primary antibody was
used to detect the released cytochrome c (1:5000 in TBST). The second-
ary antibody was goat-anti-mouse conjugated to HRP (1:2000). The
bandswere visualized by EZ-ECL detection kit. Anti-VDAC primary anti-
body (1:1000 in TBST) was used on the same membrane as a control
without the need to strip the membrane since VDAC and cytochrome
c have different molecular weights and hence no cross-reactivity can
be seen.
2.7.1. A note of the exogenous ceramide additions
We note that the amounts of ceramides exogenously added tomito-
chondria or liposomes are higher than physiological ceramide concen-
trations, however, only a very small percentage of the ceramide added
to solution inserts into mitochondrial membranes [10] and the local
concentration of ceramide in a particular membrane can be much
higher than the overall measured concentration.
3. Results
3.1. C22-ceramide reduces the propensity of C16-ceramide channel forma-
tion in isolated rat liver mitochondria and in liposomes
In order to study the effects of a mixture of exogenously added
ceramides on the permeabilization of isolated mitochondria, intact mi-
tochondria were incubated with C16-ceramide, C22-ceramide or a mix-
ture of C16 and C22-ceramides for 15 min at room temperature.
Mitochondrial permeability was measured thereafter using the cyto-
chrome c accessibility assay. Whereas C16-ceramide or C22-ceramide
treatment alone consistently induced more than 50% outer membrane
permeabilization, premixing both lipids together markedly reduced
the effects of each ceramide (Fig. 1A). The effect was conﬁrmed bymeasuring permeabilization in real-time by monitoring the release of
adenylate kinase. Mixing both ceramides together prior to addition to
mitochondria signiﬁcantly lowered their efﬁcacy to induce permeability
to adenylate kinase (Fig. 1B). Furthermore, this effect was also tested in
artiﬁcial liposomal membranes composed purely of lipids. Indeed, C22-
ceramide inhibited C16-channel formation in liposomes as evidenced
by the lower propensity to release carboxyﬂuorescein from the lipo-
somes (Fig. 1C). In addition, the effects of increasing the amount of
C22-ceramide compared to C16-ceramide were tested in liposomes. In-
terestingly, the effect was biphasic. As the amount of C22-ceramide be-
came larger, inhibition of C16-ceramide channel formation was evident
until the concentration of C22-ceramide became greater than that of
C16-ceramide as a reversal of the effect was observed (Fig. 1D).
3.2. Mixing different ceramides interferes with the effects of each ceramide
on membrane permeability in a dose-dependent manner
In order to show that the inhibitionwas also presentwith a different
very long chain ceramide, similar experiments were performed using
C24-ceramide as a competing species with C16-ceramide channels.
Moreover, the biphasic effect was further studied in isolated mitochon-
dria using the cytochrome c accessibility assay. Fig. 2A shows that the ef-
fect of C16-ceramide on C24-ceramide channel formation and vice versa
is biphasic. The effects of each ceramide on the other's ability to form
channels in the outer membrane were shown to be signiﬁcantly differ-
ent from the addition or the average of the effects of each ceramide spe-
cies alone (Fig. 2B) indicating the competitive nature of the inhibition.
3.3. Different ceramide species form different channels in mitochondria
Previous results indicated that different species of ceramide are
causing membrane permeability independently from each other. In
order to deduce the mechanisms by which ceramide species are perfo-
rating mitochondria, the release of two intermembrane space proteins
was compared. Adenylate kinase (AK) is a small (26 kDa) protein
whereas sulﬁte oxidase (SOX) is a large (120 kDa) enzyme of the inter-
membrane space. Isolatedmitochondriaweremixedwith C16-ceramide
(Fig. 3, top), C22-ceramide (Fig. 3,middle), or a mixture of C16- and C22-
ceramide (Fig. 3, bottom) prior to assaying AK and SOX enzymes.
Whereas C16-ceramide caused the release of SOX (Fig. 3, top), C22-
ceramide (Fig. 3, middle) showed no signiﬁcant release of this enzyme
indicating that the channels formed by C22-ceramide are much smaller
than those formed by C16-ceramide. Mixing both ceramide species led
to a release of SOX together with AK (Fig. 3, bottom). Since C22-
ceramide channels were unable to release SOX, this release was proba-
bly only due to the formation of C16-ceramide channels, or due to the
formation of a C16–C22-hybrid channel. In all, these results are consistent
with different ceramide species forming channels of different sizes, and
possibly in different numbers, in isolated mitochondria.
3.4. Cells with endogenously high levels of very long chain fatty acid
ceramides release less cytochrome c upon treatment with exogenous C16-
ceramide and vice versa
The overexpression of different CerSs in HEK cells leads to the en-
richment of speciﬁc species of ceramides in these cells. For instance,
the overexpression of CerS2 enriches cells with very long chain
ceramides (C22-, C24- and C24:1-ceramides [4]) whereas CerS5 overex-
pression leads to the accumulation of C16-ceramide. In order to conﬁrm
the effects of exogenously added ceramide on the permeability of mito-
chondrial membranes enriched with different species of ceramide, the
release of cytochrome cwas measured byWestern blotting. Exogenous
C16-ceramide was added to mitochondria isolated from HEK cells that
were overexpressing CerS2 (very long chain ceramides) or CerS5 (C16-
ceramide). The addition of C16-ceramide to cells already enriched with
C16-ceramide (CerS5-transfected) potentiates cytochrome c release
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ternatively, the addition of exogenous C24-ceramide to mitochondria
from CerS2-transfected cells enhanced the cytochrome c release and
inhibited the release in mitochondria from CerS5-transfected cells
(Fig. 4B) indicating that the competition is observed ex vivo as well.Cy
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cascade of events that culminate in apoptotic death. Various proteins
have been linked to the initiation of apoptosis by causingmitochondrial
outer membrane permeabilization via the formation of different pores
(reviewed in [27]), such as mitochondrial permeability transition pore
(mtPTP) [28], mitochondrial apoptosis-induced channel (MAC) [29],
Bax oligomerization into channels [24] and Bax/Bak hybrid channels
[30]. In addition, bioactive lipids have also been implicated in channel
formation in the outermembrane ofmitochondria, whether in conjunc-
tion with proteins [31–33] or individually [6,14,34]. In vivo, all of the
aforementioned events can take place simultaneously leading to a coor-
dinated and regulated outcome.
Here we studied themechanisms of ceramide-induced permeability
of themitochondrial outer membrane as one of the processes that leads
to apoptotic cell death. Ceramides are produced denovo from the amino
acid serine and palmitoyl-CoA in a set of reactions that end with the
desaturation of the 4–5 carbon–carbon double bond to form the bioac-
tive ceramide. The penultimate step in this pathway is a condensation
reaction between a fatty acyl-CoA and the amino alcohol sphinganine.
This reaction is catalyzed by a family of 6 mammalian isoforms of cer-
amide synthase (CerS) [35]. CerSs are localized differentially in the cell
and they are speciﬁc to different subsets of fatty acids depending on
the chain length [5]. Dihydroceramide desaturase, a mixed-functionoxidase, ﬁnally produces the characteristic 4,5 double bond creating
ceramide. Ceramides are generated in response to a plethora of stressors
to initiate the apoptotic pathway. For instance, C16-ceramide was
shown to be increased in human colon carcinoma cells following
treatment by celecoxib (a cyclooxygenase-2 selective nonsteroidal
anti-inﬂammatory drug used to treat arthritis) thus mediating its anti-
proliferative effects [36,37]. Ceramides have also been implicated in ap-
optotic death by facilitating the opening of mtPTP. For instance, C6-
ceramide was shown to enhance curcumin-induced cytotoxicity [38]
and the efﬂux of AIF from mitochondria upon curcumin treatment
was accelerated by a concerted action of Bax, VDAC and ceramide [39]
. Other reports suggest that ceramide does not interact with the
known components of mtPTP and that C18-ceramide is a natural inhib-
itor of that channel [40]. Curcumin was recently shown to induce rapid
CerS dimerization, enhancing the activity of the enzyme thus producing
more ceramide [41].
Ceramides of various fatty acyl chain lengths were shown to
permeabilize mitochondria and artiﬁcial membranes when exogenous-
ly added [10,15]. This permeability is due to their ability to form
channels in the membrane. The formation of ceramide channels is
strongly dependent on the structure of the ceramide molecule [42].
Dihydroceramide, which lacks the 4–5 trans double bond in ceramide,
is not only inactive in causing cell death but also inhibitory of ceramide
channel formation in vitro by intercalating in the ordered ceramide
channel and destabilizing it leading to channel disassembly [1]. Differ-
ent ceramide species affecting one another is not surprising as the pro-
duction of ceramides with differing chain lengths alter the biophysical
properties of membranes differentially [26,43]. Moreover, the biophys-
ical properties ofmembranes change as a result of depletion of very long
chain sphingolipids [44].
The lengths of the fatty acids of ceramide serve a variety of functions.
For example, they play important roles inmodulation of ceramide chan-
nels by the anti-apoptotic Bcl-2 family protein, Bcl-xL [15]. Bcl-xL in-
hibits ceramide channel formation [20]. This inhibition is lost if the
ceramide has a truncated fatty acyl chain indicating a role of the fatty
acid chain length in binding Bcl-xL. Bax which potentiates ceramide
channel formation, on the other hand, is insensitive to ceramide acyl
chain length. The presence of a hydrophobic pocket in Bcl-xL suggests
that binding ceramide is dependent on the ceramide's chain length.
The optimal lengths of ceramides whose channels are inhibited by Bcl-
xL were shown to be 16, 18 and 20 carbons [15]. Moreover, the roles
of ceramides with different fatty acid chain lengths in a variety of neu-
rodegenerative diseases were thoroughly discussed [45]. Depending
on the type of the neurological disorder, there are increases or decreases
in certain subsets of ceramides, indicating that the chain length is an in-
tegral functional feature of the ceramide molecule.
In this report, the effects of varying chain lengths at the level of the
ceramide molecule were investigated. Indeed, similar to our previous
results, the presence of different ceramide species in the added vehicle
caused a marked decrease in ceramide channel formation as both C22-
and C24-ceramides competed with the ability of C16-ceramide to form
channels. The effects were not protein-dependent as similar results
were obtained with protein-free unilamellar liposomes. Interestingly,
studies with liposomes conﬁrmed a biphasic nature of the inhibition.
The addition of C16-ceramide to liposomes induced the release of CF
from liposomes. As the mole fraction of C16-ceramide was decreased
in favor of C22-ceramide, the release of CF was reduced then increased
thereafter. This indicates that different channels were being formed.
At ﬁrst, C16-ceramide channels were favored and C22-ceramide inter-
fered with the channel formation capability of C16-ceramide, however
as the relative amount of C16-ceramide became less, C22-ceramide chan-
nel formation dominated. Similarly, in isolated mitochondria, this effect
was observed in the competition assays of C16- and C24-ceramides
conﬁrming the hypothesis that each ceramide species produces unique
and uniform channels and the presence of other species would be
inhibitory.
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Fig. 4. Exogenous ceramide permeabilizes mitochondria isolated from different CerSs-overexpressing cells differentially. HEK cells overexpressing CerS2, CerS5 or mock transfected with
plasmid only (pCMV) for 24 h were collected, homogenized and mitochondria were isolated. Mitochondria from pCMV-transfected cells were hypotonically-lysed (Lys) or treated with
exogenous C16-ceramide (A) or C24-ceramide (B) and the mixture was incubated for 20 min at room temperature. The other batches of isolated mitochondria were treated with C16-
ceramide or C24-ceramide in a similar manner. The suspensions were spun down and the subsequent pellets (P) and supernatants (SN) collected and ﬂash frozen for SDS-PAGE analysis
(top). Vehicle control was performed by the addition of isopropanol to isolated mitochondria (Veh). Western blotting using anti-cytochrome c primary antibody was used to detect the re-
leased cytochrome c uponmitochondrial permeabilization and anti-VDACwas used as amarker of mitochondrial membranes. The intensities of cytochrome c bands in samples from pellets
and supernatantsweremeasured by densitometry (bottom). The experimentwas performedwith three different preparations and theWestern blot shown is a representation of the results.
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form distinctive channels, we investigated the nature of each type of
channel. C16-ceramide channels were shown to form larger channels,
as SOX (a 120 kDa protein) was released in a time-dependent manner,
whereas C22-ceramide was unable to release this enzyme from the
IMS. Both ceramide species, however, were able to form pathways
large enough to release AK (a 26 kDa protein). This indicates that C16-
ceramide is able to form larger channels than C22-ceramide. Adding a
mixture of C16- and C22-ceramides leads to the release of SOX presum-
ably through the larger C16-ceramide channels. Although there is a pos-
sibility that hybrid channels comprised of both C22- and C16-ceramides
can be large enough to allow the passage of SOX outwards, it is unlikely
because the presence of both species in the same channel is
destabilizing.
In order to study the effects of different ceramide species ex vivo,
HEK cells overexpressing different CerSs were utilized. CerS5-
overexpressing HEK cells have accumulated C16-ceramide in their
membranes whereas HEK cells overexpressing CerS2 have high levels
of very long chain fatty ceramides [4,22,46]. Mitochondria isolated
from HEK cells overexpressing either enzyme or mock-transfected
with vector only were subjected to C16- or C24-ceramides. The release
of cytochrome c, measured by Western blotting, was an indication of
channel forming activity in mitochondria. Not surprisingly, mitochon-
dria from CerS2-transfected cells were more resistant to perme-
abilization by C16-ceramide and the release of cytochrome c was
potentiatedwhen C24-ceramidewas exogenously added. Similar results
were obtained with mitochondria isolated from CerS5-overexpressing
cells, with C16-ceramide potentiating cytochrome c release and C24-
ceramide inhibiting its release. These results are indicative of the pres-
ence of different mechanisms in vivo to promote or inhibit ceramide
channel formation depending on the CerS that is activated and the cer-
amide species that are produced. It should be noted that the results pre-
sented here are limited and not based on our own analysis of ceramide
contents upon overexpression of CerS2 or CerS5.
Recently, it was shown in HCT-116 human colon cancer cells as well
as in MCF-7 breast cancer cells that upregulation of CerS4 and CerS6
(both of which are responsible for the production of the long chained
C16- and C18-ceramides) induced mitochondrial damage and induction
of apoptosis. The opposite effects were observed upon overexpression
of CerS2 (which speciﬁcally acylates sphinganine with very long chainfatty acids) [22]. Co-overexpression of CerS2 with CerS4 or CerS6 led
to a marked increase in total ceramide levels, however this increase
had no effect on cell proliferation in HCT-116 cells, indicating that the
equilibrium between the various ceramide species is key to instruct
the cell to initiate the apoptotic machinery [47].
At the start of the apoptotic program, dying cells mainly produce C16
and C18-ceramides [48,49] followed by the production of C24-ceramides
as the process reaches its ﬁnal stages [48]. This selective activation of
certain CerS at the expense of others is indicative of the varying roles
each ceramide species plays to initiate or accelerate apoptosis. Channels
made from C16- and C18-ceramides are inhibited by Bcl-xL which resists
thepermeabilization of the outermembrane until signiﬁcant concentra-
tions of these ceramides are achieved. This control of apoptosis initia-
tion can be further exacerbated by the production of very long chain
ceramides in the vicinity of mitochondria containing C16- or C18-
ceramides. The key decision-making step of mitochondrial outer mem-
brane permeabilization is controlled, therefore, at several levels to en-
sure the conditions are met before executing the cell.
5. Conclusion
In all, we present evidence of a novel mechanism of apoptotic regu-
lation, whereby the activities of various CerS enzymes are coordinated
in such a way to produce a timely response. The mode of inhibition is
biophysical, and is related to the packing of different columns of cer-
amide on top of one another. The intercalation of a heterogeneous mix-
ture of ceramides within the channel columns within the plane of the
membrane is destabilizing the tight packing of the lipid columns and
possibly affects the curvature of the channel at the interface with the
mitochondrial outer membrane bilayer. This, in conjunction with
dihydroceramide inhibition of ceramide channel formation [1], repre-
sents a unique process of regulation when and where ceramide is pro-
duced to cause mitochondrial permeability and apoptosis. On the
other hand it can be used as a starting point in designing speciﬁc
drugs that activate one type of CerS but not others and thereby control-
ling the initiation of apoptosis. Furthermore, provided that CerSs are
regulated by homo- or hetero-dimerization, the activity of different
CerSs can bemodulated in a novel way in order to generate the required
acyl chain composition of ceramide in vivo [41] in agreement with the
results presented in this research.
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